Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. - Wikidata - awgldk - TriplyDB

Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction.

Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction.

http://www.wikidata.org/entity/Q33379564

about

Secretome of peripheral blood mononuclear cells enhances wound healing Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction Harnessing the Angiogenic Potential of Stem Cell-Derived Exosomes for Vascular Regeneration Bone marrow-derived cells in ocular neovascularization: contribution and mechanisms The Evolution of the Stem Cell Theory for Heart Failure Gene and cell therapies for the failing heart to prevent sudden arrhythmic death Paracrine Factors from Irradiated Peripheral Blood Mononuclear Cells Improve Skin Regeneration and Angiogenesis in a Porcine Burn Model Donor hematopoietic stem cells confer long-term marrow reconstitution by self-renewal divisions exceeding to that of host cells Peripheral blood mononuclear cell secretome for tissue repair Enhancement of cell-based therapeutic angiogenesis using a novel type of injectable scaffolds of hydroxyapatite-polymer nanocomposite microspheres Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction.Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation Stem cells derived from cord blood in transplantation and regenerative medicine.Stem cell paracrine actions and tissue regeneration.Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart Injection of human bone marrow and mononuclear cell extract into infarcted mouse hearts results in functional improvement.Intracoronary delivery of bone-marrow-derived stem cells.Secretomes of apoptotic mononuclear cells ameliorate neurological damage in rats with focal ischemia.Concentration of Rat Bone Marrow Nucleated Cells Using Hypo-osmotic Hemolysis in Distilled Water.Density gradient centrifugation compromises bone marrow mononuclear cell yield.Anti-thymocyte globulin induces neoangiogenesis and preserves cardiac function after experimental myocardial infarction.Cardiac cell therapy: where we've been, where we are, and where we should be headed.Mononuclear cell secretome protects from experimental autoimmune myocarditis Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain.Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study.Cell tracking in cardiac repair: what to image and how to image.Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction.Coculture with hematopoietic stem cells protects cardiomyocytes against apoptosis via paracrine activation of AKT Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation.Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium Analysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration.Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.The birth of 'regenerative pharmacology': a clinical perspective.Distinct mobilization of circulating CD271+ mesenchymal progenitors from hematopoietic progenitors during aging and after myocardial infarction.Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up.Image-guided therapies for myocardial repair: concepts and practical implementation.Dying blood mononuclear cell secretome exerts antimicrobial activity.Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help?Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease.Pregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration.

P2860

Q21133599-D8B44BA2-5A6B-4A9A-BF27-8BEADEB7C920 Q24314350-88B89520-8EAE-4CA3-BC30-0A786B3D71F5 Q26749039-E2CF3EA2-C462-46D6-B30E-F25BE2CE0040 Q26765959-425B22F1-8588-4B11-B6AA-0C9E948B2C76 Q26769042-31973296-A145-49D5-AF0B-C875F94B6565 Q26865425-E3274DCC-687C-4863-B301-D657D1498CC3 Q27318224-2A7A59B6-1396-41D5-8342-5EC9227DC45B Q27333660-E5BCF900-4BAE-43EF-B9EE-3EF69121E84F Q28071643-A4324BF0-F589-4D8A-8FC8-AE2272A17E35 Q31058133-3C58696B-8FA2-4138-BBCF-996B99ED537C Q33440102-255BA1B4-7FD2-4ABC-AE55-A0E7D090C526 Q33455791-A9F1025A-9A35-430D-9EA6-89DE7C1C0519 Q33568824-3A24B683-D581-4883-A364-1239CB98C3BD Q33708216-8FD137A8-B9F2-4B17-A93D-249C344A6B45 Q33734834-364CEC22-5CBB-491C-B104-869A17DC6C68 Q34253381-445A9C5E-8775-4F4A-A247-0FC9DF1DF257 Q34318046-AA8F1AE1-F4EC-440C-B2F1-C9BCA29C0F5A Q34433639-0A0EF0AA-FAF7-4FF9-B80A-A26A69A72D85 Q34498079-82C5DFEC-42AB-44E9-BF41-763D41724106 Q34510325-90E8B3DA-5E24-4CAA-8F9C-E71CA2C2EF8B Q34532985-26B2AC0D-3478-4E05-9D4A-61DB68B1EA13 Q35144550-660A0C16-9E95-47DF-B50C-0D64626FBBD3 Q35176487-C9AD511C-7619-4714-A805-8321D335A0BF Q35540734-F3D917F1-F346-4C3B-8BD0-7A902787223A Q35587397-68E7BA32-8557-4335-AD9A-9B22ADA0D528 Q35589728-387BBDF3-9A64-456B-9F8E-9FE0B62E3781 Q35633590-4ADC5090-98E8-4DDC-AB57-BF9E7CA927DC Q36127880-3CEE09B3-4ECB-4A1F-8A6B-20C57740330E Q36233665-0DDC7E28-67F9-40FF-9374-896CE001C2B3 Q36260404-2029CBB2-78B4-4F42-B9D2-9BD748E94066 Q36280879-9CBADA43-9D4F-4BBF-B423-28E8DC061432 Q36353619-F8D69A5D-0C01-41DC-A6A9-3F0BA56E0055 Q36836344-CBB0D49C-5455-4778-B295-2BDD46DCD511 Q36861611-06A3E91B-AB06-40E0-80E2-8165062E4AF8 Q37305343-31C11A7A-842C-44EE-A980-48218AAC1365 Q37383576-D7245280-2C23-43DF-8B10-15A7565AB1BF Q37420535-1490927F-0AA2-4E91-93E2-4D97C368E540 Q37506545-F4A67FFF-0508-4F0C-956C-E6B607B1634D Q37598908-41871D42-3104-44EE-99F2-7890FF371E56 Q37668953-2BAE9419-E084-4C90-8DDC-DA12014BAFF8

P2860

Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction.

http://www.wikidata.org/entity/Q33379564

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Bone marrow cells are a rich s ...... s after myocardial infarction.

@ast

Bone marrow cells are a rich s ...... s after myocardial infarction.

@en

type

label

Bone marrow cells are a rich s ...... s after myocardial infarction.

@ast

Bone marrow cells are a rich s ...... s after myocardial infarction.

@en

prefLabel

Bone marrow cells are a rich s ...... s after myocardial infarction.

@ast

Bone marrow cells are a rich s ...... s after myocardial infarction.

@en

P1433

Q33379564-452F8D5C-1DBD-46A1-8183-9EB9992ADE46

P1476

Q33379564-158852A3-2CE0-4797-BCAD-D2B346AD9F1A

P2093

Q33379564-5516B605-07BD-4F73-8C4B-756FBC7C047C

Q33379564-5BF09D6C-CBCC-46B9-A2B6-EF1B4AFA6E02

Q33379564-5F2B2E1C-A7F7-4617-BADB-7AE8C1880E35

Q33379564-717ADB48-7C94-4446-94E1-CD0B83D9ECCE

Q33379564-7B64994D-1BBB-4C84-91B5-1AB2A8CEFCA0

Q33379564-868D5875-5AA0-484D-8728-402BDCACCE23

Q33379564-8FC5660F-F830-4589-AADD-C7C3BDD0316A

Q33379564-A383FDBE-7A24-4841-B973-B4C6D8F35345

Q33379564-BB65DDB2-CBF1-4FE2-BFA9-D3ECD3C70329

P2860

Q33379564-02E9A95F-30D2-4100-BAC5-015CA06CFDCA

Q33379564-1A496379-A0DA-4290-A747-EE3028C03B6F

Q33379564-1F9D0455-0879-4153-A3B4-3AEEC0A9F0B8

Q33379564-25F783BD-C440-48D0-A944-50DCB6BEE604

Q33379564-48559FFF-7B48-4B74-B10D-E46B7ED1610E

Q33379564-4AA0BF02-EB61-4660-8553-0AECF89D41E3

Q33379564-4B0308C4-EC36-4C76-B57E-519F9E0A46A3

Q33379564-52F73B35-854E-4853-8865-C9DC076A652C

Q33379564-54BA626F-827B-4705-A99F-6FCB0C58C814

Q33379564-6ADA5550-ACB9-4478-8A66-F6121FC7D911

P304

Q33379564-A15B6FD9-E786-459C-BB2A-CCFC903FF52D

P31

Q33379564-20E363AE-5496-4B9F-9892-3D6B3C5CC117

P356

Q33379564-F3D6807D-732A-4B1D-88D4-D5E427F78347

P433

Q33379564-844A54EA-5A47-4604-900C-9D5A17FBE14C

P478

Q33379564-600FCF97-BDD6-45D5-9E49-135C915A0297

P577

Q33379564-14BCC0CA-0860-40D1-9D4D-5BC0C5A3B99F

P5875

Q33379564-9E3EA381-B09B-4140-9D9F-B12CB2AB14CC

P698

Q33379564-7E15DF8E-1224-4024-8B04-6824779D02B9

P921

Q33379564-6C6CC0CB-8153-4538-A339-0BA4E46A7D74

Q33379564-ADB6E6CD-8F06-4F94-9DB3-368959EB77EC

P356

P1433

European Heart Journal

P1476

Bone marrow cells are a rich s ...... s after myocardial infarction.

@en

P2093

Arnold Ganser

http://www.w3.org/2001/XMLSchema#string

Eva Brinkmann

http://www.w3.org/2001/XMLSchema#string

Gerd P Meyer

http://www.w3.org/2001/XMLSchema#string

Helmut Drexler

http://www.w3.org/2001/XMLSchema#string

Kai C Wollert

http://www.w3.org/2001/XMLSchema#string

Mortimer Korf-Klingebiel

http://www.w3.org/2001/XMLSchema#string

Philipp Fischer

http://www.w3.org/2001/XMLSchema#string

Thomas Sauer

http://www.w3.org/2001/XMLSchema#string

Tibor Kempf

http://www.w3.org/2001/XMLSchema#string

P2860

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

Mouse aortic ring assay: A new approach of the molecular genetics of angiogenesis

Bone marrow cells regenerate infarcted myocardium

Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan

Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair

Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders

Primary PCI for myocardial infarction with ST-segment elevation.

Bone marrow-derived cells do not incorporate into the adult growing vasculature.

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

In vitro model for the study of necrosis and apoptosis in native cartilage.

P304

2851-2858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHN456

http://www.w3.org/2001/XMLSchema#string

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23415313

http://www.w3.org/2001/XMLSchema#string

P698

18953051

http://www.w3.org/2001/XMLSchema#string

P921